Hem › Metastaserande cancer › Iowa
Kliniska studier för Metastaserande cancer i Iowa
10 studier för Metastaserande cancer söker deltagare vid platser i Iowa.
Städer i Iowa
Officiell studietext (engelska)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- och 4 fler
RekryterarFas 2
Alla åldrar · Alla kön · Uppdaterad 2 okt. 2026 · NCT05564377A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Des Moines
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06103864A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- University of Iowa, Iowa City
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07174336A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- University of Iowa, Iowa City
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT07029399A Study of ASP1002 in Adults for Treatment of Solid Tumors
- University of Iowa Hospitals, Iowa City
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 juli 2026 · NCT05719558Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- University of Iowa Health Care, Iowa City
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 11 juni 2026 · NCT052833305-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors
- University of Iowa Health Care, Iowa City
RekryterarFas 1
Ålder 18 till 99 · Alla kön · Uppdaterad 28 maj 2026 · NCT07404332A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- University of Iowa, Iowa City
RekryterarFas 2/3
Alla åldrar · Alla kön · Uppdaterad 2 apr. 2026 · NCT06581406Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
- University of Iowa Hospitals & Clinics- Holden Comprehensive Cancer Center, Iowa City
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 6 feb. 2026 · NCT06127407SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Iowa City
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.